FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2605662235> ?p ?o ?g. }

• W2605662235 abstract "Naturally acquired immunity can reduce parasitaemia and potentially influence anti-malarial treatment outcomes; however, evidence for this in the current literature provides conflicted results. The available evidence was synthesized to determine and quantify the association between host immunity and anti-malarial treatment failure. Four databases were searched to identify studies investigating malaria antibody levels in patients receiving anti-malarial treatment for symptomatic malaria with treatment failure recorded according to the World Health Organization classification. Odds ratios or hazard ratios were extracted or calculated to quantify the association between malarial antibody levels and treatment failure, and findings from different studies were visualized using forest plots. Eight studies, including patients with falciparum malaria treated with mono- and combination therapy of artemisinin derivatives, sulfadoxine, pyrimethamine and chloroquine, were identified. Reported and calculated effect estimates varied greatly between studies, even those assessing the same antigens and treatments. An association between blood-stage IgG responses and treatment efficacy was observed. The greatest magnitudes of effect were observed for artemisinin [OR/HR (95% CI) range 0.02 (0.00, 0.45)–1.08 (0.57, 2.06)] and chloroquine [0.24 (0.04, 1.37)–0.32 (0.05, 1.96)] treatments, and larger magnitudes of effect were observed for variant surface antigen responses [0.02 (0.00, 0.45)–1.92 (0.94, 3.91)] when compared with merozoite specific responses [0.24 (0.04, 1.37)–2.83 (1.13, 7.09)]. Naturally acquired malarial immunity is associated with reduced anti-malarial treatment failure in malaria endemic populations. Anti-malarial IgG effects treatment outcome differently for different anti-malarial drugs and antigen targets, and had the greatest impact during treatment with the current first-line treatments, the artemisinins. This has implications for the assessment of the therapeutic efficacy of anti-malarials, particularly in the context of emerging artemisinin resistance." @default.
• W2605662235 created "2017-04-28" @default.
• W2605662235 creator A5043730353 @default.
• W2605662235 creator A5050635434 @default.
• W2605662235 creator A5052537138 @default.
• W2605662235 creator A5056280353 @default.
• W2605662235 date "2017-04-20" @default.
• W2605662235 modified "2023-10-12" @default.
• W2605662235 title "Immunity as a predictor of anti-malarial treatment failure: a systematic review" @default.
• W2605662235 cites W1670737453 @default.
• W2605662235 cites W1967015536 @default.
• W2605662235 cites W1972036562 @default.
• W2605662235 cites W1973200069 @default.
• W2605662235 cites W1979423827 @default.
• W2605662235 cites W1985805028 @default.
• W2605662235 cites W1987311633 @default.
• W2605662235 cites W1988341219 @default.
• W2605662235 cites W1992148637 @default.
• W2605662235 cites W2000369867 @default.
• W2605662235 cites W2005501262 @default.
• W2605662235 cites W2010272823 @default.
• W2605662235 cites W2012593576 @default.
• W2605662235 cites W2040095486 @default.
• W2605662235 cites W2049204605 @default.
• W2605662235 cites W2056183462 @default.
• W2605662235 cites W2056672999 @default.
• W2605662235 cites W2097432479 @default.
• W2605662235 cites W2109205591 @default.
• W2605662235 cites W2113251371 @default.
• W2605662235 cites W2114445005 @default.
• W2605662235 cites W2115445412 @default.
• W2605662235 cites W2120267418 @default.
• W2605662235 cites W2128319492 @default.
• W2605662235 cites W2137252590 @default.
• W2605662235 cites W2145633183 @default.
• W2605662235 cites W2159056342 @default.
• W2605662235 cites W2161311583 @default.
• W2605662235 cites W2161510631 @default.
• W2605662235 cites W2162196946 @default.
• W2605662235 cites W2162842262 @default.
• W2605662235 cites W2165244263 @default.
• W2605662235 cites W2168521097 @default.
• W2605662235 cites W2171102256 @default.
• W2605662235 cites W2531269403 @default.
• W2605662235 cites W2588681363 @default.
• W2605662235 cites W2595300397 @default.
• W2605662235 doi "https://doi.org/10.1186/s12936-017-1815-y" @default.
• W2605662235 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5397737" @default.
• W2605662235 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28427418" @default.
• W2605662235 hasPublicationYear "2017" @default.
• W2605662235 type Work @default.
• W2605662235 sameAs 2605662235 @default.
• W2605662235 citedByCount "13" @default.
• W2605662235 countsByYear W26056622352017 @default.
• W2605662235 countsByYear W26056622352019 @default.
• W2605662235 countsByYear W26056622352020 @default.
• W2605662235 countsByYear W26056622352021 @default.
• W2605662235 countsByYear W26056622352022 @default.
• W2605662235 countsByYear W26056622352023 @default.
• W2605662235 crossrefType "journal-article" @default.
• W2605662235 hasAuthorship W2605662235A5043730353 @default.
• W2605662235 hasAuthorship W2605662235A5050635434 @default.
• W2605662235 hasAuthorship W2605662235A5052537138 @default.
• W2605662235 hasAuthorship W2605662235A5056280353 @default.
• W2605662235 hasBestOaLocation W26056622351 @default.
• W2605662235 hasConcept C126322002 @default.
• W2605662235 hasConcept C142724271 @default.
• W2605662235 hasConcept C156957248 @default.
• W2605662235 hasConcept C185032368 @default.
• W2605662235 hasConcept C190612196 @default.
• W2605662235 hasConcept C203014093 @default.
• W2605662235 hasConcept C2776120307 @default.
• W2605662235 hasConcept C2776539918 @default.
• W2605662235 hasConcept C2777035104 @default.
• W2605662235 hasConcept C2777425658 @default.
• W2605662235 hasConcept C2778048844 @default.
• W2605662235 hasConcept C2778301690 @default.
• W2605662235 hasConcept C2778371730 @default.
• W2605662235 hasConcept C2779341262 @default.
• W2605662235 hasConcept C2779997623 @default.
• W2605662235 hasConcept C2780441369 @default.
• W2605662235 hasConcept C71924100 @default.
• W2605662235 hasConcept C8891405 @default.
• W2605662235 hasConceptScore W2605662235C126322002 @default.
• W2605662235 hasConceptScore W2605662235C142724271 @default.
• W2605662235 hasConceptScore W2605662235C156957248 @default.
• W2605662235 hasConceptScore W2605662235C185032368 @default.
• W2605662235 hasConceptScore W2605662235C190612196 @default.
• W2605662235 hasConceptScore W2605662235C203014093 @default.
• W2605662235 hasConceptScore W2605662235C2776120307 @default.
• W2605662235 hasConceptScore W2605662235C2776539918 @default.
• W2605662235 hasConceptScore W2605662235C2777035104 @default.
• W2605662235 hasConceptScore W2605662235C2777425658 @default.
• W2605662235 hasConceptScore W2605662235C2778048844 @default.
• W2605662235 hasConceptScore W2605662235C2778301690 @default.
• W2605662235 hasConceptScore W2605662235C2778371730 @default.
• W2605662235 hasConceptScore W2605662235C2779341262 @default.
• W2605662235 hasConceptScore W2605662235C2779997623 @default.
• W2605662235 hasConceptScore W2605662235C2780441369 @default.
• W2605662235 hasConceptScore W2605662235C71924100 @default.

• next